Haleon (HLN) broke ground on its new Global Oral Health Innovation Centre in Weybridge, Surrey. This state-of-the-art facility will enhance Haleon’s science capabilities, accelerate innovation, and serve as a centre of excellence for global oral health research.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HLN:
- Haleon Completes Acquisition of Remaining Stake in China JV
- Haleon Completes First Tranche of Share Buyback Program
- Haleon PLC Executes Share Buyback to Enhance Shareholder Value
- Haleon names Carl Haney as Chief Research & Development Officer
- Haleon price target raised to 503 GBp from 502 GBp at Berenberg